<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archivearticle1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mediators Inflamm</journal-id><journal-id journal-id-type="iso-abbrev">Mediators Inflamm</journal-id><journal-id journal-id-type="publisher-id">MI</journal-id><journal-title-group><journal-title>Mediators of Inflammation</journal-title></journal-title-group><issn pub-type="ppub">0962-9351</issn><issn pub-type="epub">1466-1861</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5075643</article-id><article-id pub-id-type="doi">10.1155/2016/1258504</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>ATP Induces IL-1<italic>&#x003b2;</italic> Secretion in<italic> Neisseria gonorrhoeae</italic>-Infected Human Macrophages by a Mechanism Not Related to the NLRP3/ASC/Caspase-1 Axis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Garc&#x000ed;a</surname><given-names>Killen</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Escobar</surname><given-names>Gisselle</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Mendoza</surname><given-names>Pablo</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Beltran</surname><given-names>Caroll</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Perez</surname><given-names>Claudio</given-names></name><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-3421-2920</contrib-id><name><surname>Arancibia</surname><given-names>Sergio</given-names></name><xref ref-type="aff" rid="I4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Vernal</surname><given-names>Rolando</given-names></name><xref ref-type="aff" rid="I5">
<sup>5</sup>
</xref><xref ref-type="aff" rid="I6">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-8071-1229</contrib-id><name><surname>Rodas</surname><given-names>Paula I.</given-names></name><xref ref-type="aff" rid="I7">
<sup>7</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Acu&#x000f1;a-Castillo</surname><given-names>Claudio</given-names></name><xref ref-type="aff" rid="I8">
<sup>8</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-1587-4179</contrib-id><name><surname>Escobar</surname><given-names>Alejandro</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Instituto de Investigaci&#x000f3;n en Ciencias Odontol&#x000f3;gicas, Facultad de Odontolog&#x000ed;a, Universidad de Chile, Santiago, Chile</aff><aff id="I2"><sup>2</sup>Departamento de Gastroenterolog&#x000ed;a, Hospital Cl&#x000ed;nico de la Universidad de Chile, Santiago, Chile</aff><aff id="I3"><sup>3</sup>Banco de Sangre, Hospital Cl&#x000ed;nico de la Universidad de Chile, Santiago, Chile</aff><aff id="I4"><sup>4</sup>Investigaci&#x000f3;n y Desarrollo, Laboratorio Centrovet, Santiago, Chile</aff><aff id="I5"><sup>5</sup>Departamento de Odontolog&#x000ed;a Conservadora, Facultad de Odontolog&#x000ed;a, Universidad de Chile, Santiago, Chile</aff><aff id="I6"><sup>6</sup>Unidad de Odontolog&#x000ed;a, Facultad de Ciencias de la Salud, Universidad Aut&#x000f3;noma de Chile, Santiago, Chile</aff><aff id="I7"><sup>7</sup>Center for Integrative Medicine and Innovative Science, Facultad de Medicina, Universidad Andr&#x000e9;s Bello, Santiago, Chile</aff><aff id="I8"><sup>8</sup>Laboratorio de Inmunolog&#x000ed;a, Departamento de Biolog&#x000ed;a, Facultad de Qu&#x000ed;mica y Biolog&#x000ed;a, Universidad de Santiago de Chile, Santiago, Chile</aff><author-notes><corresp id="cor1">*Alejandro Escobar: <email>janodvm@gmail.com</email></corresp><fn fn-type="other"><p>Academic Editor: Vera L. Petricevich</p></fn></author-notes><pub-date pub-type="ppub"><year>2016</year></pub-date><pub-date pub-type="epub"><day>10</day><month>10</month><year>2016</year></pub-date><volume>2016</volume><elocation-id>1258504</elocation-id><history><date date-type="received"><day>15</day><month>5</month><year>2016</year></date><date date-type="rev-recd"><day>12</day><month>8</month><year>2016</year></date><date date-type="accepted"><day>6</day><month>9</month><year>2016</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2016 Killen Garc&#x000ed;a et al.</copyright-statement><copyright-year>2016</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>
<italic>Neisseria gonorrhoeae</italic> (Ngo) has developed multiple immune evasion mechanisms involving the innate and adaptive immune responses. Recent findings have reported that Ngo reduces the IL-1<italic>&#x003b2;</italic> secretion of infected human monocyte-derived macrophages (MDM). Here, we investigate the role of adenosine triphosphate (ATP) in production and release of IL-1<italic>&#x003b2;</italic> in Ngo-infected MDM. We found that the exposure of Ngo-infected MDM to ATP increases IL-1<italic>&#x003b2;</italic> levels about ten times compared with unexposed Ngo-infected MDM (<italic>P</italic> &#x0003c; 0.01). However, we did not observe any changes in inflammasome transcriptional activation of speck-like protein containing a caspase recruitment domain (CARD) (ASC, <italic>P</italic> &#x0003e; 0.05) and caspase-1 (CASP1, <italic>P</italic> &#x0003e; 0.05). In addition, ATP was not able to modify caspase-1 activity in Ngo-infected MDM but was able to increase pyroptosis (<italic>P</italic> &#x0003e; 0.01). Notably ATP treatment defined an increase of positive staining for IL-1<italic>&#x003b2;</italic> with a distinctive intracellular pattern of distribution. Collectively, these data demonstrate that ATP induces IL-1<italic>&#x003b2;</italic> secretion by a mechanism not related to the NLRP3/ASC/caspase-1 axis and likely is acting at the level of vesicle trafficking or pore formation.</p></abstract><funding-group><award-group><funding-source>Universidad de Chile</funding-source></award-group></funding-group></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>
<italic>Neisseria gonorrhoeae</italic> (Ngo) or gonococcus, a Gram-negative diplococcus, is the etiological agent of the sexually transmitted bacterial infection (STI) gonorrhoea. Gonorrhea is the second most frequent STI worldwide, where the total number of new cases of gonorrhea in adults was estimated to be 106.1 million cases out of 498.9 million with STI [<xref rid="B2" ref-type="bibr">1</xref>]. Clinical data also indicates that previous gonococcal infections do not improve immune response in patients with reinfection, which suggest that immunological memory is not induced by gonococcus [<xref rid="B3" ref-type="bibr">2</xref>]. Since the ineffective immune response against gonococcus is multifactorial, it has been hypothesized that it could be the sum of different mechanisms. One of them may be related to genital tissue properties, such as immune privileged site in the female tract [<xref rid="B4" ref-type="bibr">3</xref>, <xref rid="B5" ref-type="bibr">4</xref>], while the other could involve evasion mechanisms intrinsically developed by the bacteria, such as phase and antigenic variations [<xref rid="B6" ref-type="bibr">5</xref>], epitope mimicry [<xref rid="B7" ref-type="bibr">6</xref>], and phagosome subversion to overcome immune defence [<xref rid="B8" ref-type="bibr">7</xref>]. On the other hand, Ngo has several mechanisms for evading complement-mediated defences, such as LOS sialylation [<xref rid="B9" ref-type="bibr">8</xref>] and binding of PorB molecules to the complement cascade inhibitors factor H and complement factor 4b-binding protein (C4BP) [<xref rid="B10" ref-type="bibr">9</xref>].</p><p>The current data suggest that Ngo is able to suppress the protective innate cellular immune response at different levels. Even though phagocytosis by neutrophils (PMN) is generally a dead end for bacteria, it has been demonstrated that the number of intracellular Ngo cells and the number of bacteria per intracellular phagosome inside neutrophils increase over time [<xref rid="B12" ref-type="bibr">10</xref>&#x02013;<xref rid="B11" ref-type="bibr">12</xref>]. Moreover, Ngo use multiple mechanisms to defend themselves against other ROS; nonoxidative antibacterial factors of PMN must act on the bacteria, which implies that these factors are not sufficient to clear infection [<xref rid="B14" ref-type="bibr">13</xref>]. On the other hand, macrophages (M&#x003a6;) and dendritic cells (DC) are critical cells in the innate immune response; it has been showed that Ngo potently inhibits the ability of antigen-primed bone-marrow-derived DC (BMDC) to trigger T-cell proliferation by inducing expression of both immunosuppressive cytokines and tolerance-inducing cell surface protein [<xref rid="B15" ref-type="bibr">14</xref>]. Recent findings of our laboratory have demonstrated that human monocyte-derived macrophages (MDM) were induced to a M2 profile when they were infected with Ngo. No significant differences were observed in IL-1<italic>&#x003b2;</italic> levels in comparison to gonococcus-treated macrophages and M0-macrophages suggesting that Ngo could trigger insufficient IL-1<italic>&#x003b2;</italic> levels to activate innate immune response, which leads to chronic inflammatory condition with no pathogen destruction [<xref rid="B16" ref-type="bibr">15</xref>].</p><p>IL-1<italic>&#x003b2;</italic> is described as a proinflammatory cytokine that is crucial for host-defense responses to infection and injury [<xref rid="B17" ref-type="bibr">16</xref>]. IL-1<italic>&#x003b2;</italic> needs two independent signals to be properly active and functionally released: a priming step where a first signal in response to pathogen associated molecular patterns (PAMP) induces pro-IL-1<italic>&#x003b2;</italic> expression [<xref rid="B18" ref-type="bibr">17</xref>] and a second signal which transforms pro-IL-1<italic>&#x003b2;</italic> in its mature and functional form (IL-1<italic>&#x003b2;</italic>) for proper release. This second signal is mediated by a protein complex named inflammasome, which prompts activation of the IL-1<italic>&#x003b2;</italic> converting enzyme caspase-1 [<xref rid="B19" ref-type="bibr">18</xref>], although it has been shown in other cells like PMN that production of IL-1<italic>&#x003b2;</italic> is not entirely dependent on caspase-1 and several serine proteases including CG, NE, and PR3 can also process pro-IL-1<italic>&#x003b2;</italic> [<xref rid="B20" ref-type="bibr">19</xref>].</p><p>In macrophages, multiple distinct bacterial products signals stimulate the NLRP3 inflammasome, resulting in the proteolytic activation of caspase-1 [<xref rid="B21" ref-type="bibr">20</xref>&#x02013;<xref rid="B23" ref-type="bibr">22</xref>]. NLRP3 has a tripartite structure with a PAMP/danger associated molecular patterns (DAMP) sensing C-terminal leucine-rich repeat (LRR), a central nucleotide binding (or NACHT) domain, and an N-terminal pyrin domain (PYD) [<xref rid="B24" ref-type="bibr">23</xref>]. The PYD domain of NLRP3 recruits the adaptor molecule apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC), which recruits pro-caspase-1 and produces caspase-1 activation [<xref rid="B24" ref-type="bibr">23</xref>].</p><p>Many pathogens have different mechanisms to disrupt inflammasome activation and therefore IL-1<italic>&#x003b2;</italic> production [<xref rid="B25" ref-type="bibr">24</xref>]. Thus, the searching for strategies to overcome this disruption is an important goal to be addressed. To date, three models of NLRP3 activation in response to microbial ligands have been proposed: K<sup>+</sup> efflux, lysosomal rupture, and ROS production [<xref rid="B26" ref-type="bibr">25</xref>&#x02013;<xref rid="B28" ref-type="bibr">27</xref>]. Additionally, endogenous DAMP such as extracellular ATP on macrophages produces a variety of cellular effects, including a maturation and release of IL-1<italic>&#x003b2;</italic> by inflammasome activation [<xref rid="B29" ref-type="bibr">28</xref>]. ATP can be secreted under a broad range of conditions including antigen presentation and macrophage interaction with bacteria or microbial products such as LPS [<xref rid="B30" ref-type="bibr">29</xref>].<italic> In vitro</italic> studies have demonstrated that ATP ligation of the P2X7 also stimulates killing of intracellular chlamydiae and mycobacteria in infected macrophages [<xref rid="B31" ref-type="bibr">30</xref>&#x02013;<xref rid="B33" ref-type="bibr">32</xref>]. In addition, gingival epithelial cells infected with<italic> P. gingivalis</italic> secrete IL-1<italic>&#x003b2;</italic> only after stimulation with extracellular ATP [<xref rid="B34" ref-type="bibr">33</xref>]. Therefore, we tested the hypothesis that the addition of an exogenous source of ATP promotes the IL-1<italic>&#x003b2;</italic> processing and release during Ngo infection in human monocyte-derived macrophages (MDM). We demonstrated that ATP stimulation increases the secretion of IL-1<italic>&#x003b2;</italic> in Ngo-infected MDM. Interestingly, high levels of IL-1<italic>&#x003b2;</italic> did not correlate with the activation of inflammasome-mediated caspase-1, as previously observed in other microorganisms [<xref rid="B34" ref-type="bibr">33</xref>&#x02013;<xref rid="B36" ref-type="bibr">35</xref>] suggesting that ATP-induced IL-1<italic>&#x003b2;</italic> secretion could be acting at the level of mechanisms related to vesicle trafficking or pore formation.</p></sec><sec id="sec2"><title>2. Materials and Methods</title><sec id="sec2.1"><title>2.1. Blood Samples</title><p>Human buffy coats were provided by volunteers after informed consent. The study was approved by the Scientific Ethics Committee of Hospital Cl&#x000ed;nico Universidad de Chile (approval number 58). After sample collection, a trial number was assigned to each donor with their demographic data and the database was anonymised.</p></sec><sec id="sec2.2"><title>2.2. Bacteria and Culture Conditions</title><p>
<italic>Neisseria gonorrhoeae</italic> P9-17 strain used in this study was kindly provided by Dr. Myron Christodoulides (University of Southampton, UK). Gonococcal vials were taken from frozen stocks, plated on Thayer Martin plates (LaboratorioLinsan, Chile), and cultured at 37&#x000b0;C in 5% CO<sub>2</sub> for 18 to 20 hours. Single colonies with Pil<sup>+</sup> Opa<sup>+</sup> phenotype were reisolated for subsequent experiments.</p></sec><sec id="sec2.3"><title>2.3. Monocyte-Derived Macrophage (MDM) Generation</title><p>Human monocytes were obtained from normal blood donor buffy coats by two-step gradient centrifugation followed by an additional step using RosetteSep&#x02122; Human Monocyte Enrichment Cocktail (STEMCELL Technologies). Monocyte-derived macrophages (MDM) were obtained by culturing monocytes (84% CD14<sup>+</sup>) for 7 days in RPMI 1640 (GIBCO, Invitrogen Corporation) supplemented with 10% FBS (HyClone), 50&#x02009;U/mL penicillin, 50&#x02009;<italic>&#x003bc;</italic>g/mL streptomycin (Gibco Invitrogen), and 50&#x02009;ng/mL of M-CSF (MiltenyiBiotec) in 6-well plates at a density of 2 &#x000d7; 10<sup>6</sup> cells per well.</p></sec><sec id="sec2.4"><title>2.4. ATP Solution Preparation</title><p>The necessary amount of ATP (product number A6419 Sigma-Aldrich, MO, USA) for experiment was weighed in a Eppendorf tube. Ten minutes before cells stimulation, ATP was diluted in nonsupplemented RPMI-1640 medium to generate a 10&#x02009;mM ATP solution. Then ATP solution was filtered using syringe filter (pore size 0.2&#x02009;<italic>&#x003bc;</italic>m) and it was immediately added to the cells to reach a 5&#x02009;mM concentration.</p></sec><sec id="sec2.5"><title>2.5. MDM Infection and Treatment with ATP</title><p>Bacterial suspensions were prepared in 1&#x02009;mL serum-free RPMI1640 medium. MDM were infected with Ngo at a multiplicity of infection (MOI) of 100 for 4 hours at 37&#x000b0;C and 5% CO<sub>2</sub>. Then cultures were treated with gentamicin (100&#x02009;<italic>&#x003bc;</italic>g/mL) (Invitrogen Corp., Carlsbad, CA) to kill extracellular bacteria for 2&#x02009;h at 37&#x000b0;C and 5% CO<sub>2</sub>. Medium was replaced by nonsupplemented (serum-free and antibiotic-free) RPMI and then 5&#x02009;mM ATP (Sigma-Aldrich, MO, USA) was added and incubated for 30 minutes at 37&#x000b0;C 5% CO<sub>2</sub>. Finally, the supernatants were collected for IL-1<italic>&#x003b2;</italic>, while cells were lysed for RNA extraction.</p></sec><sec id="sec2.6"><title>2.6. Measurement of Secreted IL-1<italic>&#x003b2;</italic>
</title><p>IL-1<italic>&#x003b2;</italic> levels were measured in supernatants immediately after 30-minute treatment with ATP by enzyme-linked immunosorbent assays using ELISA Ready-SET-Go! (eBioscience, USA, sensitivity 2&#x02009;pg/mL), according to the manufacturer's instructions.</p></sec><sec id="sec2.7"><title>2.7. Quantitative Real-Time PCR (qRT-PCR)</title><p>Total RNA was extracted (purified) from MDM as described previously [<xref rid="B37" ref-type="bibr">36</xref>]. Reverse transcription (5&#x02009;<italic>&#x003bc;</italic>g) was performed using the Transcriptor First-Strand cDNA synthesis kit following the manufacturer's recommendations (Roche Applied Science, Mannheim, Germany). To quantify the mRNA expression of<italic> IL-1&#x003b2;</italic>,<italic> NLRP3</italic>,<italic> ASC</italic>, and<italic> CASP-1</italic>, 50&#x02009;ng of cDNA was amplified by quantitative real-time PCR using the appropriate primers and the SybrGreen Master Mix (Fermentas) in a StepOne&#x02122; Real-Time PCR System (Applied Biosystems&#x02122;, California, USA). The cycle program used was 95&#x000b0;C for 10&#x02009;min, followed by 40 cycles of 95&#x000b0;C for 15&#x02009;s, 60&#x000b0;C for 30&#x02009;s, and 72&#x000b0;C for 30&#x02009;s. Primer sequences were as follows: 5&#x02032;-CTTCCTTTCCAGTTTGCTGC-3&#x02032; forward and 5&#x02032;-TCTCGCAGTCCACTTCCTTT-3&#x02032; reverse for<italic> NLRP3</italic>, 5&#x02032;-AGTTTCACACCAGCCTGGAA-3&#x02032; forward and 5&#x02032;-TTTTCAAGCTGGCTTTTCGT-3&#x02032; reverse for<italic> ASC</italic>, 5&#x02032;-GCCCAAGTTTGAAGGACAAA-3&#x02032; forward and 5&#x02032;-GGTGTGGAAGAGCAGAAAGC-3&#x02032; reverse for<italic> CASP-1</italic>, 5&#x02032;-CTGTCCTGCGTGTTGAAAGA-3&#x02032; forward and 5&#x02032;-TTGGGTAATTTTTGGGATCTACA-3&#x02032; reverse for IL-1<italic>&#x003b2;</italic>, and 5&#x02032;-CTAACACGGGAAACCTCAC-3&#x02032; forward and 5&#x02032;-CGCTCCACCAACTAAGAACG-3&#x02032; reverse for 18S. The fold change in expression of the target gene relative to the 18S endogenous control was set at 2<sup>&#x02212;&#x00394;&#x00394;Ct</sup>, where &#x00394;&#x00394;Ct = (CtTarget &#x02212; Ct18S) stimulated &#x02212; (CtTarget &#x02212; Ct18S) unstimulated.</p></sec><sec id="sec2.8"><title>2.8. Detection of Enzymatically Active Caspase-1 and Apoptosis by Flow Cytometry</title><p>A FAM-FLICA caspase-1 assay kit (ImmunoChemistry Technologies) was used to detect caspase-1 enzymatic activity according to the manufacturer's instructions. FLICA was diluted and added to wells containing infected, ATP-treated or nontreated cells. The cells were cultured for 4 hours and MDM were then collected and subjected to flow-cytometric analysis (Facscalibur, Becton-Dickinson, San Diego, CA, USA) to quantify the percentage of FAM-FLICA-positive MDM. Apoptosis of MDM cells was measured using an FITC Annexin V Apoptosis Detection Kit with 7-AAD (BioLegend). Data analysis was performed using WinMDI 2.8 (freeware).</p></sec><sec id="sec2.9"><title>2.9. Immunofluorescence Microscopy Analysis</title><p>Macrophages were grown on 12 mm coverslips in 24-well plates and were treated using same conditions of cell culture previously described. After 30 minutes of ATP stimulation, cells supernatant was removed and coverslips were washed twice with sterile PBS 1x and then cells were fixed with 4% paraformaldehyde in 100&#x02009;mM PIPES buffer pH 6.8, containing 40&#x02009;mM KOH, 2&#x02009;mM EGTA, and 2&#x02009;mM MgCl<sub>2</sub> for 30 minutes. Then, cells were washed three times with washing solution (50&#x02009;mMTris buffer pH 7.6 containing 0.15&#x02009;N NaCl and 0.1% sodium azide) and permeabilized with 0.1% Triton X-100 in washing solution for 10&#x02009;min, washed twice, and then blocked with 2% bovine serum albumin for 60&#x02009;min. Intracellular IL-1<italic>&#x003b2;</italic> was evaluated by staining cells with an anti-IL-1<italic>&#x003b2;</italic> Rb pAb at 1&#x02009;:&#x02009;100 dilution (ab2105, abcam, USA), followed by a goat anti-rabbit IgG (H+L) secondary antibody, Alexa Fluor&#x000ae; 488 conjugate (A11008, Life Technologies) at 1&#x02009;:&#x02009;100 dilution. Nuclear staining was carried out using DAPI (D9542 Sigma-Aldrich, St. Louis, MO). Coverslips were washed twice and mounted on microscope slides with DAKO fluorescent mounting medium (Dako North America Inc., CA, USA) and samples were visualized with a confocal microscopy (Carl Zeiss, model LSM700).</p></sec></sec><sec id="sec3"><title>3. Results</title><sec id="sec3.1"><title>3.1. <italic>N. gonorrhoeae</italic> Induces IL-1<italic>&#x003b2;</italic> Transcription but Inhibits IL-1<italic>&#x003b2;</italic> Secretion in MDM</title><p>Previous findings of our laboratory showed that IL-1<italic>&#x003b2;</italic> present in supernatants from Ngo- infected macrophages at different MOIs was not significantly different from nonstimulated MDM [<xref rid="B16" ref-type="bibr">15</xref>]. To further explore in those results, we aimed to detect the presence of IL-1<italic>&#x003b2;</italic> from MDM infected with Ngo at 100&#x02009;MOI. As shown in <xref ref-type="fig" rid="fig1">Figure 1(a)</xref>, macrophages infected with Ngo did not show more IL-1<italic>&#x003b2;</italic> secretion than noninfected macrophages. Indeed, IL-1<italic>&#x003b2;</italic> secretion by macrophages exposed to LPS was much more than IL-1<italic>&#x003b2;</italic> secreted by Ngo-infected macrophages. However, when total mRNA levels of pro-IL-1<italic>&#x003b2;</italic> were assessed by qPCR, we observed that pro-IL-1<italic>&#x003b2;</italic> RNA levels were highly induced in response to gonococcal infection (<xref ref-type="fig" rid="fig1">Figure 1(b)</xref>), indicating that Ngo is able to trigger the signaling pathway to start pro-IL-1<italic>&#x003b2;</italic> synthesis.</p></sec><sec id="sec3.2"><title>3.2. ATP Increases IL-1<italic>&#x003b2;</italic> Levels in Culture Supernatants from Ngo-Infected Macrophages</title><p>Since the synthesis of mature IL-1<italic>&#x003b2;</italic> depends on the activation of NLRP3 inflammasome signaling pathway as a second signal [<xref rid="B38" ref-type="bibr">37</xref>], we aimed to stimulate the NLRP3 inflammasome in Ngo-infected MDM using a cognate agonist (ATP) [<xref rid="B39" ref-type="bibr">38</xref>], to establish whether gonococcus are modifying NLRP3 inflammasome activity. Our results showed that the low levels of secreted IL-1<italic>&#x003b2;</italic> from Ngo-infected MDM were increased in presence of ATP (<xref ref-type="fig" rid="fig2">Figure 2</xref>). The use of ATP was able to induce a similar cytokine production in Ngo-infected MDM as LPS stimulated MDM. It suggests that Ngo apparently is able to prevent inflammasome activation.</p></sec><sec id="sec3.3"><title>3.3. ATP Does Not Activate NLRP3 Inflammasome RNA Expression in Ngo-Infected MDM</title><p>Since one of the strategies adopted by bacterial pathogens is the inflammasome subversion [<xref rid="B22" ref-type="bibr">21</xref>] and the use of ATP contributes to the host immune response against intracellular bacteria, through its ability to stimulate P2X7-dependent IL-1<italic>&#x003b2;</italic> secretion [<xref rid="B30" ref-type="bibr">29</xref>], we decided to study whether inflammasome components<italic> NLRP3</italic>,<italic> ASC</italic>, and caspase-1 (<italic>CASP-1</italic>) might be modified by the ATP treatment in infected MDM. Data obtained from 4 independent experiments showed that ATP only modified the RNA expression levels of<italic> NLRP3</italic> in infected MDM, while the levels of<italic> ASC</italic> and<italic> CASP-1</italic> showed no significant differences with nonstimulated infected cells (<xref ref-type="table" rid="tab1">Table 1</xref>).</p></sec><sec id="sec3.4"><title>3.4. ATP Does Not Modify Caspase-1 Activity in Ngo-Infected MDM but Is Able to Increase Pyroptosis</title><p>Caspase-1 activation is necessary to process pro-IL-1<italic>&#x003b2;</italic> onto mature IL-1<italic>&#x003b2;</italic>, but ATP was not able to produce transcriptional activation of<italic> CASP-1</italic>; thus we assessed if ATP is able to modify caspase-1 activity in Ngo-infected MDM, using a fluorescent inhibitor probe FAM-YVAD-FMK to label active caspase-1 enzyme. Data obtained from 3 independent experiments showed that ATP treatment of Ngo-infected MDM was not able to induce the activation of caspase-1 in infected cells (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Activation of caspase-1 also triggers a form of cell death, known as pyroptosis [<xref rid="B40" ref-type="bibr">39</xref>]. Although trypan blue staining showed that most cells were viable after infection and ATP treatment, we performed a FITC Annexin V (AV) with 7-aminoactinomycin (7-AAD) Apoptosis Detection assay to monitor ATP-induced cell pyroptosis. Considering that the feature of pyroptosis is the positive staining with AV in contrast to negative 7-AAD staining [<xref rid="B41" ref-type="bibr">40</xref>], we compared the percentage of AV<sup>+</sup> 7-AAD<sup>&#x02212;</sup> cells. ATP was able to induce an early stage of apoptosis in gonococcus-infected MDM (<xref ref-type="fig" rid="fig4">Figure 4</xref>).</p></sec><sec id="sec3.5"><title>3.5. ATP Affects the Intracellular Distribution of IL-1<italic>&#x003b2;</italic> in Ngo-Infected MDM Cells</title><p>Since NLRP3 inflammasome is not involved in the ATP-induced IL-1<italic>&#x003b2;</italic> secretion in gonococcus-infected MDM, we aimed to observe the ability of ATP to induce a nonclassical IL-1<italic>&#x003b2;</italic> secretion by microvesicles formation [<xref rid="B42" ref-type="bibr">41</xref>]. Ngo-infected MDM treated with ATP were observed for intracellular distribution of mature IL-1<italic>&#x003b2;</italic> by immunofluorescence using confocal microscopy. Notably, ATP treatment of Ngo-infected MDM defined an increase of positive staining for IL-1<italic>&#x003b2;</italic> with a distinctive pattern of distribution (<xref ref-type="fig" rid="fig5">Figure 5(c)</xref>) as a focus formation towards membrane.</p></sec></sec><sec id="sec4"><title>4. Discussion</title><p>The current data suggest that Ngo produce lack of induction of protective immune response in macrophages and dendritic cell [<xref rid="B15" ref-type="bibr">14</xref>, <xref rid="B16" ref-type="bibr">15</xref>, <xref rid="B43" ref-type="bibr">42</xref>]. Recent findings of our laboratory have recognized that MDM are induced to a M2 profile when they are infected with Ngo and do not reach significant differences in IL-1<italic>&#x003b2;</italic> levels between gonococcus-treated macrophages and M0-macrophages [<xref rid="B16" ref-type="bibr">15</xref>]. In this work, we confirmed the lower levels of IL-1<italic>&#x003b2;</italic> in Ngo-infected human MDM (<xref ref-type="fig" rid="fig1">Figure 1(a)</xref>). Our data differ with those reported by Duncan et al. which showed that Ngo can promote NLRP3 activation and IL-1<italic>&#x003b2;</italic> secretion in human macrophages THP-1 cells [<xref rid="B44" ref-type="bibr">43</xref>]. This discrepancy might be explained by the remarkable difference between THP-1 cell line (monocytic nature) [<xref rid="B1" ref-type="bibr">44</xref>] and macrophages. The increase in the constitutive caspase-1 activation [<xref rid="B45" ref-type="bibr">45</xref>] and subsequent IL-1<italic>&#x003b2;</italic> secretion by monocytes following TLR stimulation is well recognized, whereas macrophages require a second signal [<xref rid="B46" ref-type="bibr">46</xref>]. Moreover, we showed that macrophages skewed from the M1 to M2 states, when infected with Ngo, have low levels of the Toll-like receptor-4 (TLR-4) [<xref rid="B16" ref-type="bibr">15</xref>], which has been shown to play a key role in the induction of inflammatory pathways [<xref rid="B47" ref-type="bibr">47</xref>].</p><p>The cytokine IL-1<italic>&#x003b2;</italic> is controlled by two checkpoints: transcription and maturation and release [<xref rid="B48" ref-type="bibr">48</xref>]. Our first results showed lower levels of mature IL-1<italic>&#x003b2;</italic> in Ngo-infected human MDM supernatants. However, when we looked at transcript level, we showed a sizable induction of IL-1<italic>&#x003b2;</italic> RNA upon gonococcal infection (<xref ref-type="fig" rid="fig1">Figure 1(b)</xref>). The differences in transcription versus translation of IL-1<italic>&#x003b2;</italic> induced by gonococcus in MDM cells could be due to disruption in inflammasome activity as shown in others pathogens [<xref rid="B21" ref-type="bibr">20</xref>]. Since ATP contributes to the host immune response against intracellular bacteria through its ability to stimulate IL-1<italic>&#x003b2;</italic> secretion [<xref rid="B30" ref-type="bibr">29</xref>], we showed that ATP treatment of gonococcus-infected MDM cells is able to restore IL-1<italic>&#x003b2;</italic> secretion (<xref ref-type="fig" rid="fig2">Figure 2</xref>) as shown in gingival epithelial cells infected with<italic> P. gingivalis</italic>, which only secrete IL-1<italic>&#x003b2;</italic> after stimulation with extracellular ATP [<xref rid="B34" ref-type="bibr">33</xref>]. After having established the effect of ATP on IL-1<italic>&#x003b2;</italic> production by gonococcus-treated MDM, we examined the mRNA expression of NLRP3 inflammasome-associated genes:<italic> NLRP3</italic>,<italic> ASC</italic>, and<italic> CASP-1</italic> to assess inflammasome transcriptional activity in presence of ATP. Only the<italic> NLRP3</italic> transcript was upregulated in Ngo-infected MDM cells treated with ATP (<xref ref-type="table" rid="tab1">Table 1</xref>). To date, the exact action mechanism of ATP on transcription of inflammasome is unknown. However, it is not surprising that expression of<italic> NLRP3</italic> was affected by ATP, because the ATP release may act as a danger signal to mobilize intracellular calcium, further modulating NF-<italic>&#x003ba;</italic>B activation acting through a P2Y receptor/phospholipase-C/calcium signaling pathway [<xref rid="B49" ref-type="bibr">49</xref>]. In this context, the existence of binding sequences to NF-<italic>&#x003ba;</italic>B has been demonstrated in the NLRP3 promoter in murine macrophages [<xref rid="B50" ref-type="bibr">50</xref>].</p><p>Interestingly, we did not detect any changes in transcription levels of<italic> ASC</italic> and<italic> CASP-1</italic> in Ngo-infected macrophages treated with ATP (<xref ref-type="table" rid="tab1">Table 1</xref>). The nonchange in levels of expression of<italic> ASC</italic> and<italic> CASP-1</italic> could be explained because unlike NLRP3, its transcriptional regulation is not associated with MyD88 and NF-<italic>&#x003ba;</italic>B [<xref rid="B51" ref-type="bibr">51</xref>]. In line with this, we think that the absence of changes in transcription level of ASC could be affecting caspase-1 activity in response to ATP, because the function of adaptor protein ASC is enabling the activation of caspase-1 in inflammasome. Indeed, Asc<sup>&#x02212;/&#x02212;</sup> macrophages secreted much less mature IL-1<italic>&#x003b2;</italic> than their wild-type counterparts in<italic> S. typhimurium</italic>-induced caspase-1 activation model [<xref rid="B52" ref-type="bibr">52</xref>].</p><p>Although we did not observe changes in transcription levels of CASP-1, we assessed the caspase-1 activity in Ngo-infected MDM cells treated with ATP. We did not observe any changes in caspase-1 activity between infected MDM cells with or without ATP. Interestingly, in our model of MDM cells, infection with Ngo does not induce pyroptosis compared with uninfected MDM cells, unlike what is reported by Duncan et al., who showed that Ngo infection promotes NLRP3-dependent THP-1 cell death via pyronecrosis [<xref rid="B44" ref-type="bibr">43</xref>]. However, when infected MDM cells were treated with ATP, we observed an induction of early apoptotic cells (AV<sup>+</sup> 7AAD<sup>&#x02212;</sup>). Even though pyroptosis is caspase-1-dependent, we do not discard other mechanisms that induce apoptosis. As showed by previous works, extracellular ATP induces apoptotic signaling in different cells types using different pathways that link purinergic receptors to induce apoptosis and necrosis [<xref rid="B53" ref-type="bibr">53</xref>&#x02013;<xref rid="B55" ref-type="bibr">55</xref>].</p><p>Our results showed that ATP was not able to activate caspase-1 at RNA and protein level in Ngo-infected macrophages (<xref ref-type="table" rid="tab1">Table 1</xref> and <xref ref-type="fig" rid="fig3">Figure 3</xref>). Since pro-IL-1<italic>&#x003b2;</italic> and pro-IL-18 are the substrates<italic> in vitro</italic> and<italic> in vivo</italic> of caspase-1 [<xref rid="B56" ref-type="bibr">56</xref>], we hypothesize that IL-1<italic>&#x003b2;</italic> secretion induced by ATP in Ngo-infected macrophages could be at an alternative level from pro-IL-1<italic>&#x003b2;</italic> processing by NLRP3 inflammasome. In a recent report studying<italic> Porphyromonas gingivalis-</italic>infected mice macrophages, IL-1<italic>&#x003b2;</italic> secretion was inhibited by the pathogen fimbriae through inflammasome independent P2X7R mechanisms, suggesting that, in this pathological context, the IL-1<italic>&#x003b2;</italic> absence was due to unknown secretory signaling pathway involving P2X7R [<xref rid="B57" ref-type="bibr">57</xref>].</p><p>Using confocal microscopy, we attempted to localize the presence and distribution of mature IL-1<italic>&#x003b2;</italic>, where it was clearly visible that Ngo-infected MDM induced a pattern of the mature IL-1<italic>&#x003b2;</italic> arrangement with stained points dispersed in the cells. This dispersion of mature IL-1<italic>&#x003b2;</italic> as stained points was changed to concentrated and polarized points (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Since the secretion mechanism to IL-1<italic>&#x003b2;</italic> does not correspond to the classic cytokine ER-Golgi pathway [<xref rid="B58" ref-type="bibr">58</xref>] and its secretion could be carried by intracellular vesicles, secretion lysosome exocytosis, or direct passing through the cellular membrane [<xref rid="B42" ref-type="bibr">41</xref>], we speculate that one of the possibilities in the downmodulation of IL-1<italic>&#x003b2;</italic> secretion by gonococcus could be due to a mechanism related to pore formation. Indeed, during pyroptosis, pores open in the cell membrane and this structural change could promote the cellular release of interleukin-1<italic>&#x003b2;</italic> [<xref rid="B40" ref-type="bibr">39</xref>]. Moreover, as shown by Pelegrin and Surprenant, pannexin-1 (Panx1) could be a functional link between P2X7R-activated large pore formation and cytokine release in macrophage. In this sense, the activation of P2X7-receptor triggers the recruitment of an accessory pore-forming mechanism [<xref rid="B59" ref-type="bibr">59</xref>, <xref rid="B60" ref-type="bibr">60</xref>]; the Panx1 protein knockdown and panx1-mimetic inhibitory peptide are able to block ATP-mediated IL-1<italic>&#x003b2;</italic> release in mouse and human macrophage [<xref rid="B61" ref-type="bibr">61</xref>]. This issue was not assessed in this work and further studies are required to investigate this phenomenon.</p></sec><sec id="sec5"><title>5. Conclusion</title><p>In this work, we demonstrated that<italic> N. gonorrhoeae</italic> probably evades host defence by not activating the NLRP3 inflammasome in macrophages and showed that extracellular ATP is likely to act at the level of vesicle trafficking or pore formation. A better understanding of mechanisms that produce the IL-1<italic>&#x003b2;</italic> downmodulation by gonococcus will further contribute to the advance of our knowledge on<italic> N. gonorrhoeae</italic> pathogenesis and let us find a therapeutic strategy for treatment of gonococcus infection.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work was supported by Grant FIOUCH ENLACE 003/2015 from Direcci&#x000f3;n de Investigaci&#x000f3;n, Facultad de Odontolog&#x000ed;a, Universidad de Chile. The authors would like to thank Mr. Juan Fern&#x000e1;ndez from the language and translation services of the faculty for kindly proofreading and checking the spelling and grammar of this paper.</p></ack><sec><title>Competing Interests</title><p>The authors declare that there is no conflict of interests regarding the publication of this paper.</p></sec><ref-list><ref id="B2"><label>1</label><element-citation publication-type="book"><collab>WHO</collab><source><italic>Global Incidence and Prevalence of Selected Curable Sexually Transmitted Infections-2008</italic></source><year>2012</year><publisher-loc>Geneva, Switzerland</publisher-loc><publisher-name>WHO</publisher-name></element-citation></ref><ref id="B3"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hedges</surname><given-names>S. R.</given-names></name><name><surname>Mayo</surname><given-names>M. S.</given-names></name><name><surname>Mestecky</surname><given-names>J.</given-names></name><name><surname>Hook</surname><given-names>E. W.</given-names><suffix>III</suffix></name><name><surname>Russell</surname><given-names>M. W.</given-names></name></person-group><article-title>Limited local and systemic antibody responses to Neisseria gonorrhoeae during uncomplicated genital infections</article-title><source><italic>Infection and Immunity</italic></source><year>1999</year><volume>67</volume><issue>8</issue><fpage>3937</fpage><lpage>3946</lpage><pub-id pub-id-type="other">2-s2.0-0032769613</pub-id><pub-id pub-id-type="pmid">10417159</pub-id></element-citation></ref><ref id="B4"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imarai</surname><given-names>M.</given-names></name><name><surname>Candia</surname><given-names>E.</given-names></name><name><surname>Rodriguez-Tirado</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Regulatory T cells are locally induced during intravaginal infection of mice with Neisseria gonorrhoeae</article-title><source><italic>Infection and Immunity</italic></source><year>2008</year><volume>76</volume><issue>12</issue><fpage>5456</fpage><lpage>5465</lpage><pub-id pub-id-type="doi">10.1128/IAI.00552-08</pub-id><pub-id pub-id-type="other">2-s2.0-57349186538</pub-id><pub-id pub-id-type="pmid">18824531</pub-id></element-citation></ref><ref id="B5"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niederkorn</surname><given-names>J. Y.</given-names></name></person-group><article-title>See no evil, hear no evil, do no evil: the lessons of immune privilege</article-title><source><italic>Nature Immunology</italic></source><year>2006</year><volume>7</volume><issue>4</issue><fpage>354</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1038/ni1328</pub-id><pub-id pub-id-type="other">2-s2.0-33645107513</pub-id><pub-id pub-id-type="pmid">16550198</pub-id></element-citation></ref><ref id="B6"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Woude</surname><given-names>M. W.</given-names></name><name><surname>B&#x000e4;umler</surname><given-names>A. J.</given-names></name></person-group><article-title>Phase and antigenic variation in bacteria</article-title><source><italic>Clinical Microbiology Reviews</italic></source><year>2004</year><volume>17</volume><issue>3</issue><fpage>581</fpage><lpage>611</lpage><pub-id pub-id-type="doi">10.1128/cmr.17.3.581-611.2004</pub-id><pub-id pub-id-type="other">2-s2.0-3242757523</pub-id><pub-id pub-id-type="pmid">15258095</pub-id></element-citation></ref><ref id="B7"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harvey</surname><given-names>H. A.</given-names></name><name><surname>Swords</surname><given-names>W. E.</given-names></name><name><surname>Apicella</surname><given-names>M. A.</given-names></name></person-group><article-title>The mimicry of human glycolipids and glycosphingolipids by the lipooligosaccharides of pathogenic <italic>Neisseria</italic> and <italic>Haemophilus</italic>
</article-title><source><italic>Journal of Autoimmunity</italic></source><year>2001</year><volume>16</volume><issue>3</issue><fpage>257</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1006/jaut.2000.0477</pub-id><pub-id pub-id-type="other">2-s2.0-0034988798</pub-id><pub-id pub-id-type="pmid">11334490</pub-id></element-citation></ref><ref id="B8"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Billker</surname><given-names>O.</given-names></name><name><surname>Popp</surname><given-names>A.</given-names></name><name><surname>Brinkmann</surname><given-names>V.</given-names></name><etal/></person-group><article-title>Distinct mechanisms of internalization of Neisseria gonorrhoeae by members of the CEACAM receptor family involving Rac1- and Cdc42-dependent and -independent pathways</article-title><source><italic>EMBO Journal</italic></source><year>2002</year><volume>21</volume><issue>4</issue><fpage>560</fpage><lpage>571</lpage><pub-id pub-id-type="doi">10.1093/emboj/21.4.560</pub-id><pub-id pub-id-type="other">2-s2.0-0037083747</pub-id><pub-id pub-id-type="pmid">11847104</pub-id></element-citation></ref><ref id="B9"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gill</surname><given-names>M. J.</given-names></name><name><surname>Mcquillen</surname><given-names>D. P.</given-names></name><name><surname>Van Putten</surname><given-names>J. P. M.</given-names></name><etal/></person-group><article-title>Functional characterization of a sialyltransferase-deficient mutant of Neisseria gonorrhoeae</article-title><source><italic>Infection and Immunity</italic></source><year>1996</year><volume>64</volume><issue>8</issue><fpage>3374</fpage><lpage>3378</lpage><pub-id pub-id-type="other">2-s2.0-0030017019</pub-id><pub-id pub-id-type="pmid">8757878</pub-id></element-citation></ref><ref id="B10"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ram</surname><given-names>S.</given-names></name><name><surname>McQuillen</surname><given-names>D. P.</given-names></name><name><surname>Gulati</surname><given-names>S.</given-names></name><name><surname>Elkins</surname><given-names>C.</given-names></name><name><surname>Pangburn</surname><given-names>M. K.</given-names></name><name><surname>Rice</surname><given-names>P. A.</given-names></name></person-group><article-title>Binding of complement factor H to loop 5 of porin protein 1A: a molecular mechanism of serum resistance of nonsialylated <italic>Neisseria gonorrhoeae</italic>
</article-title><source><italic>The Journal of Experimental Medicine</italic></source><year>1998</year><volume>188</volume><issue>4</issue><fpage>671</fpage><lpage>680</lpage><pub-id pub-id-type="doi">10.1084/jem.188.4.671</pub-id><pub-id pub-id-type="other">2-s2.0-0032541390</pub-id><pub-id pub-id-type="pmid">9705949</pub-id></element-citation></ref><ref id="B12"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casey</surname><given-names>S. G.</given-names></name><name><surname>Veale</surname><given-names>D. R.</given-names></name><name><surname>Smith</surname><given-names>H.</given-names></name></person-group><article-title>Demonstration of intracellular growth of gonococci in human phagocytes using spectinomycin to kill extracellular organisms</article-title><source><italic>Journal of General Microbiology</italic></source><year>1979</year><volume>113</volume><issue>2</issue><fpage>395</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.1099/00221287-113-2-395</pub-id><pub-id pub-id-type="other">2-s2.0-0018726974</pub-id><pub-id pub-id-type="pmid">159942</pub-id></element-citation></ref><ref id="B13"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veale</surname><given-names>D. R.</given-names></name><name><surname>Goldner</surname><given-names>M.</given-names></name><name><surname>Penn</surname><given-names>C. W.</given-names></name><name><surname>Ward</surname><given-names>J.</given-names></name><name><surname>Smith</surname><given-names>H.</given-names></name></person-group><article-title>The intracellular survival and growth of gonococci in human phagocytes</article-title><source><italic>Journal of General Microbiology</italic></source><year>1979</year><volume>113</volume><issue>2</issue><fpage>383</fpage><lpage>393</lpage><pub-id pub-id-type="doi">10.1099/00221287-113-2-383</pub-id><pub-id pub-id-type="other">2-s2.0-0018682844</pub-id><pub-id pub-id-type="pmid">117078</pub-id></element-citation></ref><ref id="B11"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casey</surname><given-names>S. G.</given-names></name><name><surname>Shafer</surname><given-names>W. M.</given-names></name><name><surname>Spitznagel</surname><given-names>J. K.</given-names></name></person-group><article-title>Neisseria gonorrhoeae survive intraleukocytic oxygen-independent antimicrobial capacities of anaerobic and aerobic granulocytes in the presence of pyocin lethal for extracellular gonococci</article-title><source><italic>Infection and Immunity</italic></source><year>1986</year><volume>52</volume><issue>2</issue><fpage>384</fpage><lpage>389</lpage><pub-id pub-id-type="other">2-s2.0-0022641012</pub-id><pub-id pub-id-type="pmid">2870986</pub-id></element-citation></ref><ref id="B14"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Criss</surname><given-names>A. K.</given-names></name><name><surname>Seifert</surname><given-names>H. S.</given-names></name></person-group><article-title>A bacterial siren song: intimate interactions between Neisseria and neutrophils</article-title><source><italic>Nature Reviews Microbiology</italic></source><year>2012</year><volume>10</volume><issue>3</issue><fpage>178</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1038/nrmicro2713</pub-id><pub-id pub-id-type="other">2-s2.0-84857191002</pub-id><pub-id pub-id-type="pmid">22290508</pub-id></element-citation></ref><ref id="B15"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>W.</given-names></name><name><surname>Ventevogel</surname><given-names>M. S.</given-names></name><name><surname>Knilans</surname><given-names>K. J.</given-names></name><etal/></person-group><article-title>Neisseria gonorrhoeae suppresses dendritic cell-induced, antigen-dependent CD4 T cell proliferation</article-title><source><italic>PLoS ONE</italic></source><year>2012</year><volume>7</volume><issue>7, article e41260</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0041260</pub-id><pub-id pub-id-type="other">2-s2.0-84864266780</pub-id></element-citation></ref><ref id="B16"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortiz</surname><given-names>M. C.</given-names></name><name><surname>Lefimil</surname><given-names>C.</given-names></name><name><surname>Rodas</surname><given-names>P. I.</given-names></name><etal/></person-group><article-title>
<italic>Neisseria gonorrhoeae</italic> modulates immunity by polarizing human macrophages to <italic>&#x003b1;</italic> M2 profile</article-title><source><italic>PLoS ONE</italic></source><year>2015</year><volume>10</volume><issue>6</issue><pub-id pub-id-type="publisher-id">e0130713</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0130713</pub-id><pub-id pub-id-type="other">2-s2.0-84938704360</pub-id></element-citation></ref><ref id="B17"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Castejon</surname><given-names>G.</given-names></name><name><surname>Brough</surname><given-names>D.</given-names></name></person-group><article-title>Understanding the mechanism of IL-1<italic>&#x003b2;</italic> secretion</article-title><source><italic>Cytokine and Growth Factor Reviews</italic></source><year>2011</year><volume>22</volume><issue>4</issue><fpage>189</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1016/j.cytogfr.2011.10.001</pub-id><pub-id pub-id-type="other">2-s2.0-81155134753</pub-id><pub-id pub-id-type="pmid">22019906</pub-id></element-citation></ref><ref id="B18"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeuchi</surname><given-names>O.</given-names></name><name><surname>Akira</surname><given-names>S.</given-names></name></person-group><article-title>Pattern recognition receptors and inflammation</article-title><source><italic>Cell</italic></source><year>2010</year><volume>140</volume><issue>6</issue><fpage>805</fpage><lpage>820</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.01.022</pub-id><pub-id pub-id-type="other">2-s2.0-77950343791</pub-id><pub-id pub-id-type="pmid">20303872</pub-id></element-citation></ref><ref id="B19"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schroder</surname><given-names>K.</given-names></name><name><surname>Tschopp</surname><given-names>J.</given-names></name></person-group><article-title>The inflammasomes</article-title><source><italic>Cell</italic></source><year>2010</year><volume>140</volume><issue>6</issue><fpage>821</fpage><lpage>832</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.01.040</pub-id><pub-id pub-id-type="other">2-s2.0-77950362382</pub-id><pub-id pub-id-type="pmid">20303873</pub-id></element-citation></ref><ref id="B20"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guma</surname><given-names>M.</given-names></name><name><surname>Ronacher</surname><given-names>L.</given-names></name><name><surname>Liu-Bryan</surname><given-names>R.</given-names></name><name><surname>Takai</surname><given-names>S.</given-names></name><name><surname>Karin</surname><given-names>M.</given-names></name><name><surname>Corr</surname><given-names>M.</given-names></name></person-group><article-title>Caspase 1-independent activation of interleukin-1<italic>&#x003b2;</italic> in neutrophil-predominant inflammation</article-title><source><italic>Arthritis &#x00026; Rheumatism</italic></source><year>2009</year><volume>60</volume><issue>12</issue><fpage>3642</fpage><lpage>3650</lpage><pub-id pub-id-type="doi">10.1002/art.24959</pub-id><pub-id pub-id-type="other">2-s2.0-73249139175</pub-id><pub-id pub-id-type="pmid">19950258</pub-id></element-citation></ref><ref id="B21"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>C.-S.</given-names></name><name><surname>Shin</surname><given-names>D.-M.</given-names></name><name><surname>Jo</surname><given-names>E.-K.</given-names></name></person-group><article-title>The role of NLR-related protein 3 inflammasome in host defense and inflammatory diseases</article-title><source><italic>International Neurourology Journal</italic></source><year>2012</year><volume>16</volume><issue>1</issue><fpage>2</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.5213/inj.2012.16.1.2</pub-id><pub-id pub-id-type="other">2-s2.0-84866907391</pub-id><pub-id pub-id-type="pmid">22500248</pub-id></element-citation></ref><ref id="B22"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anand</surname><given-names>P. K.</given-names></name><name><surname>Malireddi</surname><given-names>R. K. S.</given-names></name><name><surname>Kanneganti</surname><given-names>T.-D.</given-names></name></person-group><article-title>Role of the Nlrp3 inflammasome in microbial infection</article-title><source><italic>Frontiers in Microbiology</italic></source><year>2011</year><volume>2, article 12</volume><pub-id pub-id-type="doi">10.3389/fmicb.2011.00012</pub-id><pub-id pub-id-type="other">2-s2.0-83355174404</pub-id></element-citation></ref><ref id="B23"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hise</surname><given-names>A. G.</given-names></name><name><surname>Tomalka</surname><given-names>J.</given-names></name><name><surname>Ganesan</surname><given-names>S.</given-names></name><etal/></person-group><article-title>An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen <italic>Candida albicans</italic>
</article-title><source><italic>Cell Host and Microbe</italic></source><year>2009</year><volume>5</volume><issue>5</issue><fpage>487</fpage><lpage>497</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2009.05.002</pub-id><pub-id pub-id-type="other">2-s2.0-65549154784</pub-id><pub-id pub-id-type="pmid">19454352</pub-id></element-citation></ref><ref id="B24"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mariathasan</surname><given-names>S.</given-names></name></person-group><article-title>ASC, Ipaf and Cryopyrin/Nalp3: bona fide intracellular adapters of the caspase-1 inflammasome</article-title><source><italic>Microbes and Infection</italic></source><year>2007</year><volume>9</volume><issue>5</issue><fpage>664</fpage><lpage>671</lpage><pub-id pub-id-type="doi">10.1016/j.micinf.2007.01.017</pub-id><pub-id pub-id-type="other">2-s2.0-34247165763</pub-id><pub-id pub-id-type="pmid">17382568</pub-id></element-citation></ref><ref id="B25"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rathinam</surname><given-names>V. A. K.</given-names></name><name><surname>Vanaja</surname><given-names>S. K.</given-names></name><name><surname>Fitzgerald</surname><given-names>K. A.</given-names></name></person-group><article-title>Regulation of inflammasome signaling</article-title><source><italic>Nature Immunology</italic></source><year>2012</year><volume>13</volume><issue>4</issue><fpage>333</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1038/ni.2237</pub-id><pub-id pub-id-type="other">2-s2.0-84858688293</pub-id><pub-id pub-id-type="pmid">22430786</pub-id></element-citation></ref><ref id="B26"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>B. K.</given-names></name><name><surname>Wen</surname><given-names>H.</given-names></name><name><surname>Ting</surname><given-names>J. P.-Y.</given-names></name></person-group><article-title>The Inflammasome NLRs in immunity, inflammation, and associated diseases</article-title><source><italic>Annual Review of Immunology</italic></source><year>2011</year><volume>29</volume><fpage>707</fpage><lpage>735</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-031210-101405</pub-id><pub-id pub-id-type="other">2-s2.0-79953046719</pub-id></element-citation></ref><ref id="B27"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;trilli</surname><given-names>V.</given-names></name><name><surname>Papin</surname><given-names>S.</given-names></name><name><surname>Dostert</surname><given-names>C.</given-names></name><name><surname>Mayor</surname><given-names>A.</given-names></name><name><surname>Martinon</surname><given-names>F.</given-names></name><name><surname>Tschopp</surname><given-names>J.</given-names></name></person-group><article-title>Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration</article-title><source><italic>Cell Death and Differentiation</italic></source><year>2007</year><volume>14</volume><issue>9</issue><fpage>1583</fpage><lpage>1589</lpage><pub-id pub-id-type="doi">10.1038/sj.cdd.4402195</pub-id><pub-id pub-id-type="other">2-s2.0-34548027736</pub-id><pub-id pub-id-type="pmid">17599094</pub-id></element-citation></ref><ref id="B28"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>R.</given-names></name><name><surname>Yazdi</surname><given-names>A. S.</given-names></name><name><surname>Menu</surname><given-names>P.</given-names></name><name><surname>Tschopp</surname><given-names>J.</given-names></name></person-group><article-title>A role for mitochondria in NLRP3 inflammasome activation</article-title><source><italic>Nature</italic></source><year>2011</year><volume>469</volume><issue>7329</issue><fpage>221</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1038/nature09663</pub-id><pub-id pub-id-type="pmid">21124315</pub-id></element-citation></ref><ref id="B29"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yilmaz</surname><given-names>&#x000d6;.</given-names></name><name><surname>Yao</surname><given-names>L.</given-names></name><name><surname>Maeda</surname><given-names>K.</given-names></name><etal/></person-group><article-title>ATP scavenging by the intracellular pathogen Porphyromonas gingivalis inhibits P2X7-mediated host-cell apoptosis</article-title><source><italic>Cellular Microbiology</italic></source><year>2008</year><volume>10</volume><issue>4</issue><fpage>863</fpage><lpage>875</lpage><pub-id pub-id-type="doi">10.1111/j.1462-5822.2007.01089.x</pub-id><pub-id pub-id-type="other">2-s2.0-40749157178</pub-id><pub-id pub-id-type="pmid">18005240</pub-id></element-citation></ref><ref id="B30"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coutinho-Silva</surname><given-names>R.</given-names></name><name><surname>Ojcius</surname><given-names>D. M.</given-names></name></person-group><article-title>Role of extracellular nucleotides in the immune response against intracellular bacteria and protozoan parasites</article-title><source><italic>Microbes and Infection</italic></source><year>2012</year><volume>14</volume><issue>14</issue><fpage>1271</fpage><lpage>1277</lpage><pub-id pub-id-type="doi">10.1016/j.micinf.2012.05.009</pub-id><pub-id pub-id-type="other">2-s2.0-84870249420</pub-id><pub-id pub-id-type="pmid">22634346</pub-id></element-citation></ref><ref id="B31"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coutinho-Silva</surname><given-names>R.</given-names></name><name><surname>Stahl</surname><given-names>L.</given-names></name><name><surname>Raymond</surname><given-names>M. N.</given-names></name><etal/></person-group><article-title>Inhibition of chlamydial infectious activity due to P2X7R-dependent phospholipase D activation</article-title><source><italic>Immunity</italic></source><year>2003</year><volume>19</volume><issue>3</issue><fpage>403</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1016/s1074-7613(03)00235-8</pub-id><pub-id pub-id-type="pmid">14499115</pub-id></element-citation></ref><ref id="B32"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darville</surname><given-names>T.</given-names></name><name><surname>Welter-Stahl</surname><given-names>L.</given-names></name><name><surname>Cruz</surname><given-names>C.</given-names></name><name><surname>Sater</surname><given-names>A. A.</given-names></name><name><surname>Andrews</surname><given-names>C. W.</given-names><suffix>Jr.</suffix></name><name><surname>Ojcius</surname><given-names>D. M.</given-names></name></person-group><article-title>Effect of the purinergic receptor P2X7 on Chlamydia infection in cervical epithelial cells and vaginally infected mice</article-title><source><italic>Journal of Immunology</italic></source><year>2007</year><volume>179</volume><issue>6</issue><fpage>3707</fpage><lpage>3714</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.179.6.3707</pub-id><pub-id pub-id-type="other">2-s2.0-35748978219</pub-id></element-citation></ref><ref id="B33"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fairbairn</surname><given-names>I. P.</given-names></name><name><surname>Stober</surname><given-names>C. B.</given-names></name><name><surname>Kumararatne</surname><given-names>D. S.</given-names></name><name><surname>Lammas</surname><given-names>D. A.</given-names></name></person-group><article-title>ATP-mediated killing of intracellular mycobacteria by macrophages is a P2X7-dependent process inducing bacterial death by phagosome-lysosome fusion</article-title><source><italic>Journal of Immunology</italic></source><year>2001</year><volume>167</volume><issue>6</issue><fpage>3300</fpage><lpage>3307</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.167.6.3300</pub-id><pub-id pub-id-type="other">2-s2.0-0035884935</pub-id></element-citation></ref><ref id="B34"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yilmaz</surname><given-names>&#x000d6;.</given-names></name><name><surname>Sater</surname><given-names>A. A.</given-names></name><name><surname>Yao</surname><given-names>L.</given-names></name><name><surname>Koutouzis</surname><given-names>T.</given-names></name><name><surname>Pettengill</surname><given-names>M.</given-names></name><name><surname>Ojcius</surname><given-names>D. M.</given-names></name></person-group><article-title>ATP-dependent activation of an inflammasome in primary gingival epithelial cells infected by <italic>Porphyromonas gingivalis</italic>
</article-title><source><italic>Cellular Microbiology</italic></source><year>2010</year><volume>12</volume><issue>2</issue><fpage>188</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1111/j.1462-5822.2009.01390.x</pub-id><pub-id pub-id-type="other">2-s2.0-77649198160</pub-id><pub-id pub-id-type="pmid">19811501</pub-id></element-citation></ref><ref id="B35"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ali</surname><given-names>S. R.</given-names></name><name><surname>Timmer</surname><given-names>A. M.</given-names></name><name><surname>Bilgrami</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Anthrax toxin induces macrophage death by p38 MAPK inhibition but leads to inflammasome activation via ATP leakage</article-title><source><italic>Immunity</italic></source><year>2011</year><volume>35</volume><issue>1</issue><fpage>34</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2011.04.015</pub-id><pub-id pub-id-type="other">2-s2.0-79960450059</pub-id><pub-id pub-id-type="pmid">21683629</pub-id></element-citation></ref><ref id="B36"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelk</surname><given-names>P.</given-names></name><name><surname>Abd</surname><given-names>H.</given-names></name><name><surname>Claesson</surname><given-names>R.</given-names></name><name><surname>Sandstr&#x000f6;m</surname><given-names>G.</given-names></name><name><surname>Sj&#x000f6;stedt</surname><given-names>A.</given-names></name><name><surname>Johansson</surname><given-names>A.</given-names></name></person-group><article-title>Cellular and molecular response of human macrophages exposed to <italic>Aggregatibacter actinomycetemcomitans</italic> leukotoxin</article-title><source><italic>Cell Death and Disease</italic></source><year>2011</year><volume>2</volume><issue>3, article e126</issue><pub-id pub-id-type="doi">10.1038/cddis.2011.6</pub-id><pub-id pub-id-type="other">2-s2.0-79953241392</pub-id></element-citation></ref><ref id="B37"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vernal</surname><given-names>R.</given-names></name><name><surname>Vel&#x000e1;squez</surname><given-names>E.</given-names></name><name><surname>Gamonal</surname><given-names>J.</given-names></name><name><surname>Garcia-Sanz</surname><given-names>J. A.</given-names></name><name><surname>Silva</surname><given-names>A.</given-names></name><name><surname>Sanz</surname><given-names>M.</given-names></name></person-group><article-title>Expression of proinflammatory cytokines in osteoarthritis of the temporomandibular joint</article-title><source><italic>Archives of Oral Biology</italic></source><year>2008</year><volume>53</volume><issue>10</issue><fpage>910</fpage><lpage>915</lpage><pub-id pub-id-type="doi">10.1016/j.archoralbio.2008.04.004</pub-id><pub-id pub-id-type="other">2-s2.0-49149129234</pub-id><pub-id pub-id-type="pmid">18508030</pub-id></element-citation></ref><ref id="B38"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haneklaus</surname><given-names>M.</given-names></name><name><surname>O'Neill</surname><given-names>L. A. J.</given-names></name></person-group><article-title>NLRP3 at the interface of metabolism and inflammation</article-title><source><italic>Immunological Reviews</italic></source><year>2015</year><volume>265</volume><issue>1</issue><fpage>53</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1111/imr.12285</pub-id><pub-id pub-id-type="other">2-s2.0-84927779736</pub-id><pub-id pub-id-type="pmid">25879283</pub-id></element-citation></ref><ref id="B39"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gombault</surname><given-names>A.</given-names></name><name><surname>Baron</surname><given-names>L.</given-names></name><name><surname>Couillin</surname><given-names>I.</given-names></name></person-group><article-title>ATP release and purinergic signaling in NLRP3 inflammasome activation</article-title><source><italic>Frontiers in Immunology</italic></source><year>2012</year><volume>3, article 414</volume><pub-id pub-id-type="doi">10.3389/fimmu.2012.00414</pub-id><pub-id pub-id-type="other">2-s2.0-84874280249</pub-id></element-citation></ref><ref id="B40"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miao</surname><given-names>E. A.</given-names></name><name><surname>Leaf</surname><given-names>I. A.</given-names></name><name><surname>Treuting</surname><given-names>P. M.</given-names></name><etal/></person-group><article-title>Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria</article-title><source><italic>Nature Immunology</italic></source><year>2010</year><volume>11</volume><issue>12</issue><fpage>1136</fpage><lpage>1142</lpage><pub-id pub-id-type="doi">10.1038/ni.1960</pub-id><pub-id pub-id-type="other">2-s2.0-78449269290</pub-id><pub-id pub-id-type="pmid">21057511</pub-id></element-citation></ref><ref id="B41"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miao</surname><given-names>E. A.</given-names></name><name><surname>Rajan</surname><given-names>J. V.</given-names></name><name><surname>Aderem</surname><given-names>A.</given-names></name></person-group><article-title>Caspase-1-induced pyroptotic cell death</article-title><source><italic>Immunological Reviews</italic></source><year>2011</year><volume>243</volume><issue>1</issue><fpage>206</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1111/j.1600-065X.2011.01044.x</pub-id><pub-id pub-id-type="other">2-s2.0-80052179138</pub-id><pub-id pub-id-type="pmid">21884178</pub-id></element-citation></ref><ref id="B42"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piccioli</surname><given-names>P.</given-names></name><name><surname>Rubartelli</surname><given-names>A.</given-names></name></person-group><article-title>The secretion of IL-1<italic>&#x003b2;</italic> and options for release</article-title><source><italic>Seminars in Immunology</italic></source><year>2013</year><volume>25</volume><issue>6</issue><fpage>425</fpage><lpage>429</lpage><pub-id pub-id-type="doi">10.1016/j.smim.2013.10.007</pub-id><pub-id pub-id-type="other">2-s2.0-84892856957</pub-id><pub-id pub-id-type="pmid">24201029</pub-id></element-citation></ref><ref id="B43"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Escobar</surname><given-names>A.</given-names></name><name><surname>Candia</surname><given-names>E.</given-names></name><name><surname>Reyes-Cerpa</surname><given-names>S.</given-names></name><etal/></person-group><article-title>
<italic>Neisseria gonorrhoeae</italic> induces a tolerogenic phenotype in macrophages to modulate host immunity</article-title><source><italic>Mediators of Inflammation</italic></source><year>2013</year><volume>2013</volume><fpage>9</fpage><pub-id pub-id-type="publisher-id">127017</pub-id><pub-id pub-id-type="doi">10.1155/2013/127017</pub-id><pub-id pub-id-type="other">2-s2.0-84885601919</pub-id></element-citation></ref><ref id="B44"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duncan</surname><given-names>J. A.</given-names></name><name><surname>Gao</surname><given-names>X.</given-names></name><name><surname>Huang</surname><given-names>M. T.-H.</given-names></name><etal/></person-group><article-title>
<italic>Neisseria gonorrhoeae</italic> activates the proteinase cathepsin B to mediate the signaling activities of the NLRP3 and ASC-containing inflammasome</article-title><source><italic>The Journal of Immunology</italic></source><year>2009</year><volume>182</volume><issue>10</issue><fpage>6460</fpage><lpage>6469</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0802696</pub-id><pub-id pub-id-type="other">2-s2.0-70449448992</pub-id><pub-id pub-id-type="pmid">19414800</pub-id></element-citation></ref><ref id="B1"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuchiya</surname><given-names>S.</given-names></name><name><surname>Yamabe</surname><given-names>M.</given-names></name><name><surname>Yamaguchi</surname><given-names>Y.</given-names></name><name><surname>Kobayashi</surname><given-names>Y.</given-names></name><name><surname>Konno</surname><given-names>T.</given-names></name><name><surname>Tada</surname><given-names>K.</given-names></name></person-group><article-title>Establishment and characterization of a human acute monocytic leukemia cell line (THP-1)</article-title><source><italic>International Journal of Cancer</italic></source><year>1980</year><volume>26</volume><issue>2</issue><fpage>171</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1002/ijc.2910260208</pub-id><pub-id pub-id-type="other">2-s2.0-0018871095</pub-id><pub-id pub-id-type="pmid">6970727</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Netea</surname><given-names>M. G.</given-names></name><name><surname>Nold-Petry</surname><given-names>C. A.</given-names></name><name><surname>Nold</surname><given-names>M. F.</given-names></name><etal/></person-group><article-title>Differential requirement for the activation of the inflammasome for processing and release of IL-1<italic>&#x003b2;</italic> in monocytes and macrophages</article-title><source><italic>Blood</italic></source><year>2009</year><volume>113</volume><issue>10</issue><fpage>2324</fpage><lpage>2335</lpage><pub-id pub-id-type="doi">10.1182/blood-2008-03-146720</pub-id><pub-id pub-id-type="other">2-s2.0-64049084303</pub-id><pub-id pub-id-type="pmid">19104081</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burchett</surname><given-names>S. K.</given-names></name><name><surname>Weaver</surname><given-names>W. M.</given-names></name><name><surname>Westall</surname><given-names>J. A.</given-names></name><name><surname>Larsen</surname><given-names>A.</given-names></name><name><surname>Kronheim</surname><given-names>S.</given-names></name><name><surname>Wilson</surname><given-names>C. B.</given-names></name></person-group><article-title>Regulation of tumor necrosis factor/cachectin and IL-1 secretion in human mononuclear phagocytes</article-title><source><italic>Journal of Immunology</italic></source><year>1988</year><volume>140</volume><issue>10</issue><fpage>3473</fpage><lpage>3481</lpage><pub-id pub-id-type="other">2-s2.0-0023936157</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>M.</given-names></name><name><surname>John</surname><given-names>C. M.</given-names></name><name><surname>Jarvis</surname><given-names>G. A.</given-names></name></person-group><article-title>Phosphoryl moieties of lipid a from <italic>Neisseria meningitidis</italic> and <italic>N. gonorrhoeae</italic> lipooligosaccharides play an important role in activation of both MyD88-and TRIF-dependent TLR4-MD-2 signaling pathways</article-title><source><italic>Journal of Immunology</italic></source><year>2010</year><volume>185</volume><issue>11</issue><fpage>6974</fpage><lpage>6984</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1000953</pub-id><pub-id pub-id-type="other">2-s2.0-78650669108</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dinarello</surname><given-names>C. A.</given-names></name></person-group><article-title>Immunological and inflammatory functions of the interleukin-1 family</article-title><source><italic>Annual Review of Immunology</italic></source><year>2009</year><volume>27</volume><fpage>519</fpage><lpage>550</lpage><pub-id pub-id-type="doi">10.1146/annurev.immunol.021908.132612</pub-id><pub-id pub-id-type="other">2-s2.0-62649139025</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Oliveira</surname><given-names>S.</given-names></name><name><surname>L&#x000f3;pez-Mu&#x000f1;oz</surname><given-names>A.</given-names></name><name><surname>Candel</surname><given-names>S.</given-names></name><name><surname>Pelegr&#x000ed;n</surname><given-names>P.</given-names></name><name><surname>Calado</surname><given-names>&#x000c2;.</given-names></name><name><surname>Mulero</surname><given-names>V.</given-names></name></person-group><article-title>ATP modulates acute inflammation in vivo through dual oxidase 1-derived H<sub>2</sub>O<sub>2</sub> production and NF-<italic>&#x003ba;</italic>B activation</article-title><source><italic>Journal of Immunology</italic></source><year>2014</year><volume>192</volume><issue>12</issue><fpage>5710</fpage><lpage>5719</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1302902</pub-id><pub-id pub-id-type="other">2-s2.0-84902137578</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiao</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>P.</given-names></name><name><surname>Qi</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Gao</surname><given-names>C.</given-names></name></person-group><article-title>TLR-induced NF-<italic>&#x003ba;</italic>B activation regulates NLRP3 expression in murine macrophages</article-title><source><italic>FEBS Letters</italic></source><year>2012</year><volume>586</volume><issue>7</issue><fpage>1022</fpage><lpage>1026</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2012.02.045</pub-id><pub-id pub-id-type="other">2-s2.0-84862807232</pub-id><pub-id pub-id-type="pmid">22569257</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>A.</given-names></name><name><surname>Wang</surname><given-names>P.</given-names></name><name><surname>Ma</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Mechanisms that lead to the regulation of NLRP3 inflammasome expression and activation in human dental pulp fibroblasts</article-title><source><italic>Molecular Immunology</italic></source><year>2015</year><volume>66</volume><issue>2</issue><fpage>253</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1016/j.molimm.2015.03.009</pub-id><pub-id pub-id-type="other">2-s2.0-84926290803</pub-id><pub-id pub-id-type="pmid">25863775</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mariathasan</surname><given-names>S.</given-names></name><name><surname>Newton</surname><given-names>K.</given-names></name><name><surname>Monack</surname><given-names>D. M.</given-names></name><etal/></person-group><article-title>Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf</article-title><source><italic>Nature</italic></source><year>2004</year><volume>430</volume><issue>6996</issue><fpage>213</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1038/nature02664</pub-id><pub-id pub-id-type="other">2-s2.0-3142654767</pub-id><pub-id pub-id-type="pmid">15190255</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa-Junior</surname><given-names>H. M.</given-names></name><name><surname>Mendes</surname><given-names>A. N.</given-names></name><name><surname>Davis</surname><given-names>G. H. N. G.</given-names></name><etal/></person-group><article-title>ATP-induced apoptosis involves a Ca<sup>2+</sup>-independent phospholipase A2 and 5-lipoxygenase in macrophages</article-title><source><italic>Prostaglandins and Other Lipid Mediators</italic></source><year>2009</year><volume>88</volume><issue>1-2</issue><fpage>51</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/j.prostaglandins.2008.09.004</pub-id><pub-id pub-id-type="other">2-s2.0-57649210505</pub-id><pub-id pub-id-type="pmid">18984060</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>M.-J.</given-names></name><name><surname>Lee</surname><given-names>H.-J.</given-names></name><name><surname>Kim</surname><given-names>J.-H.</given-names></name><name><surname>Kim</surname><given-names>D.-K.</given-names></name></person-group><article-title>Extracellular ATP induces apoptotic signaling in human monocyte leukemic cells, HL-60 and F-36P</article-title><source><italic>Archives of Pharmacal Research</italic></source><year>2006</year><volume>29</volume><issue>11</issue><fpage>1032</fpage><lpage>1041</lpage><pub-id pub-id-type="doi">10.1007/BF02969288</pub-id><pub-id pub-id-type="other">2-s2.0-33845358792</pub-id><pub-id pub-id-type="pmid">17146973</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>L. M.</given-names></name><name><surname>Zychlinsky</surname><given-names>A.</given-names></name><name><surname>Liu</surname><given-names>C.-C.</given-names></name><name><surname>Ojcius</surname><given-names>D. M.</given-names></name><name><surname>Young</surname><given-names>J. D.-E.</given-names></name></person-group><article-title>Extracellular ATP as a trigger for apoptosis or programmed cell death</article-title><source><italic>The Journal of Cell Biology</italic></source><year>1991</year><volume>112</volume><issue>2</issue><fpage>279</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1083/jcb.112.2.279</pub-id><pub-id pub-id-type="other">2-s2.0-0025924832</pub-id><pub-id pub-id-type="pmid">1988462</pub-id></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sollberger</surname><given-names>G.</given-names></name><name><surname>Strittmatter</surname><given-names>G. E.</given-names></name><name><surname>Garstkiewicz</surname><given-names>M.</given-names></name><name><surname>Sand</surname><given-names>J.</given-names></name><name><surname>Beer</surname><given-names>H.-D.</given-names></name></person-group><article-title>Caspase-1: the inflammasome and beyond</article-title><source><italic>Innate Immunity</italic></source><year>2014</year><volume>20</volume><issue>2</issue><fpage>115</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1177/1753425913484374</pub-id><pub-id pub-id-type="other">2-s2.0-84892746507</pub-id><pub-id pub-id-type="pmid">23676582</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramos-Junior</surname><given-names>E. S.</given-names></name><name><surname>Morandini</surname><given-names>A. C.</given-names></name><name><surname>Almeida-Da-Silva</surname><given-names>C. L. C.</given-names></name><etal/></person-group><article-title>A Dual role for P2X7 Receptor during <italic>Porphyromonas gingivalisInfection</italic>
</article-title><source><italic>Journal of Dental Research</italic></source><year>2015</year><volume>94</volume><issue>9</issue><fpage>1233</fpage><lpage>1242</lpage><pub-id pub-id-type="doi">10.1177/0022034515593465</pub-id><pub-id pub-id-type="other">2-s2.0-84940024066</pub-id><pub-id pub-id-type="pmid">26152185</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schatz</surname><given-names>G.</given-names></name><name><surname>Dobberstein</surname><given-names>B.</given-names></name></person-group><article-title>Common principles of protein translocation across membranes</article-title><source><italic>Science</italic></source><year>1996</year><volume>271</volume><issue>5255</issue><fpage>1519</fpage><lpage>1526</lpage><pub-id pub-id-type="doi">10.1126/science.271.5255.1519</pub-id><pub-id pub-id-type="other">2-s2.0-0029979607</pub-id><pub-id pub-id-type="pmid">8599107</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faria</surname><given-names>R. X.</given-names></name><name><surname>DeFarias</surname><given-names>F. P.</given-names></name><name><surname>Alves</surname><given-names>L. A.</given-names></name></person-group><article-title>Are second messengers crucial for opening the pore associated with P2X 7 receptor?</article-title><source><italic>American Journal of Physiology&#x02014;Cell Physiology</italic></source><year>2005</year><volume>288</volume><issue>2</issue><fpage>C260</fpage><lpage>C271</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00215.2004</pub-id><pub-id pub-id-type="other">2-s2.0-12144283595</pub-id><pub-id pub-id-type="pmid">15469955</pub-id></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schilling</surname><given-names>W. P.</given-names></name><name><surname>Wasylyna</surname><given-names>T.</given-names></name><name><surname>Dubyak</surname><given-names>G. R.</given-names></name><name><surname>Humphreys</surname><given-names>B. D.</given-names></name><name><surname>Sinkins</surname><given-names>W. G.</given-names></name></person-group><article-title>Maitotoxin and P2Z/P2X<sub>7</sub> purinergic receptor stimulation activate a common cytolytic pore</article-title><source><italic>American Journal of Physiology&#x02014;Cell Physiology</italic></source><year>1999</year><volume>277</volume><issue>4, part 1</issue><fpage>C766</fpage><lpage>C776</lpage></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pelegrin</surname><given-names>P.</given-names></name><name><surname>Surprenant</surname><given-names>A.</given-names></name></person-group><article-title>Pannexin-1 mediates large pore formation and interleukin-1<italic>&#x003b2;</italic> release by the ATP-gated P2X7 receptor</article-title><source><italic>The EMBO Journal</italic></source><year>2006</year><volume>25</volume><issue>21</issue><fpage>5071</fpage><lpage>5082</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7601378</pub-id><pub-id pub-id-type="other">2-s2.0-33750473352</pub-id><pub-id pub-id-type="pmid">17036048</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Ngo inhibits IL-1<italic>&#x003b2;</italic> levels in culture supernatants from infected MDM but is not able to inhibit IL-1<italic>&#x003b2;</italic> mRNA expression. MDM cells were infected with Ngo and then cytokine and RNA levels were evaluated after 30 minutes after infection. (a) Detection of IL-1<italic>&#x003b2;</italic> in culture supernatant by ELISA. (b) Transcriptional cytokine analysis by qRT-PCR. Results represent fold changes in transcript levels between no infected MDM and MDM infected with Ngo or treated with LPS. Data obtained are expressed as the mean &#x000b1; SD and represent at least 6 independent experiments. <sup><italic>&#x02217;</italic></sup>
<italic>P</italic> &#x0003c; 0.05; <sup><italic>&#x02217;&#x02217;&#x02217;&#x02217;</italic></sup>
<italic>P</italic> &#x0003c; 0.0001.</p></caption><graphic xlink:href="MI2016-1258504.001"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>ATP treatment increases IL-1<italic>&#x003b2;</italic> levels by Ngo-infected MDM. MDM cells were infected with Ngo and then treated with ATP (5&#x02009;mM) for 30 minutes. Culture supernatants were collected for measurement of IL-1<italic>&#x003b2;</italic> by ELISA. Data represent at least 4 independent experiments; bars indicate SD; <sup><italic>&#x02217;&#x02217;&#x02217;</italic></sup>
<italic>P</italic> &#x0003c; 0.001; <sup><italic>&#x02217;&#x02217;&#x02217;&#x02217;</italic></sup>
<italic>P</italic> &#x0003c; 0.0001.</p></caption><graphic xlink:href="MI2016-1258504.002"/></fig><fig id="fig3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>ATP treatment does not modify caspase-1 activity in Ngo-infected MDM. The fluorescent labeled probe of caspase-1 FAM-YVAD-FMK (FAM-FITC) was incubated with uninfected MDM, gonococcus-infected MDM (Ngo+MDM), or gonococcus-infected MDM and ATP (Ngo+MDM+ATP). After washing, the fluorescent intensity retained by the MDM was determined by flow cytometry. (a) Representative histograms from one assay are shown. (b) Percentage of positive FAM cells under different conditions. Data obtained are expressed as the mean &#x000b1; SD and represent at least three independent experiments.</p></caption><graphic xlink:href="MI2016-1258504.003"/></fig><fig id="fig4" orientation="portrait" position="float"><label>Figure 4</label><caption><p>ATP treatment is able to increase apoptosis in Ngo-infected MDM. FITC Annexin V with 7-AAD staining was performed and the MDM population was determined by flow cytometry. (a) Representatives dot plot from one assay are shown. (b) Percentage of positive Annexin V and 7-AAD cells under different conditions. Data obtained are expressed as the mean &#x000b1;&#x02009;&#x02009;SD and represent at least three independent experiments. <sup><italic>&#x02217;&#x02217;</italic></sup>
<italic>P</italic> &#x0003c; 0.01.</p></caption><graphic xlink:href="MI2016-1258504.004"/></fig><fig id="fig5" orientation="portrait" position="float"><label>Figure 5</label><caption><p>ATP modulates IL-1<italic>&#x003b2;</italic> distribution in Ngo-infected MDM cells. IL-1<italic>&#x003b2;</italic> expression was analyzed by confocal microscopy. (a) MDM cells, (b) Ngo-infected MDM. (c) Ngo-infected MDM treated with ATP. Images of IL-1<italic>&#x003b2;</italic> (green) and DAPI (blue). Arrow pointed IL-1<italic>&#x003b2;</italic> concentration. Scale bars 10&#x02009;<italic>&#x003bc;</italic>m.</p></caption><graphic xlink:href="MI2016-1258504.005"/></fig><table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Transcriptional activation of inflammasome-associated genes in MDM.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="left" colspan="1">Gene<break/>designation</th><th rowspan="2" align="center" colspan="1">Protein</th><th colspan="2" align="center" rowspan="1">Fold change<sup>a</sup>
</th></tr><tr><th align="center" rowspan="1" colspan="1">MDM+Ngo</th><th align="center" rowspan="1" colspan="1">MDM+Ngo+ATP</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<italic>NLRP3</italic>
</td><td align="center" rowspan="1" colspan="1">NLR family, pyrin domain-<break/>containing protein 3</td><td align="center" rowspan="1" colspan="1">0.67</td><td align="center" rowspan="1" colspan="1">3.45<sup>&#x02020;</sup>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>ASC</italic>
</td><td align="center" rowspan="1" colspan="1">Apoptosis-associated speck-like<break/>protein containing a caspase<break/>recruitment domain</td><td align="center" rowspan="1" colspan="1">0.54</td><td align="center" rowspan="1" colspan="1">0.63</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>CASP1</italic>
</td><td align="center" rowspan="1" colspan="1">Caspase-1</td><td align="center" rowspan="1" colspan="1">2.1</td><td align="center" rowspan="1" colspan="1">2.6</td></tr></tbody></table><table-wrap-foot><fn><p>
<sup>a</sup>Values represent fold changes in transcript levels between MDM infected with <italic>Neisseria gonorrhoeae</italic> and MDM infected with <italic>Neisseria gonorrhoeae</italic> treated with ATP. <sup>&#x02020;</sup>
<italic>P</italic> &#x0003c; 0.05. Mann&#x02013;Whitney <italic>U</italic> test.</p></fn></table-wrap-foot></table-wrap></floats-group></article>